Literature DB >> 19100909

mTOR-what does it do?

M N Hall1.   

Abstract

Target of rapamycin (TOR) is a highly conserved serine/threonine kinase that controls cell growth and metabolism in response to nutrients, growth factors, cellular energy, and stress. TOR, which was originally discovered in yeast, is conserved in all eukaryotes including plants, worms, flies, and mammals. The discovery of TOR led to a fundamental change in how we think about cell growth. It is not a spontaneous process that just happens when building blocks (nutrients) are available, but rather a highly regulated, plastic process controlled by TOR-dependent signaling pathways. TOR is found in 2 structurally and functionally distinct multiprotein complexes, TORC1 and TORC2. The 2 TOR complexes, like TOR itself, are highly conserved. Mammalian TORC1 (mTORC1) is rapamycin sensitive and contains mTOR, raptor, and mLST8. TORC1 in yeast and mammals mediates temporal control of cell growth by regulating several cellular processes, including translation, transcription, ribosome biogenesis, nutrient transport, and autophagy. mTORC2 is rapamycin insensitive and contains mTOR, rictor, mSIN1, PRR5, and mLST8. TORC2 in yeast and mammals mediates spatial control of cell growth by regulating the actin cytoskeleton. Thus, the 2 TOR complexes constitute an ancestral signaling network conserved throughout eukaryotic evolution to control the fundamental process of cell growth. As a central controller of cell growth, TOR plays a key role in development and aging and has been implicated in disorders such as cancer, cardiovascular disease, obesity, and diabetes. The challenge now is to understand the role of mTOR signaling to coordinate and integrate overall body growth in multicellular organisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100909     DOI: 10.1016/j.transproceed.2008.10.009

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  79 in total

1.  PRAS40 regulates protein synthesis and cell cycle in C2C12 myoblasts.

Authors:  Abid A Kazi; Charles H Lang
Journal:  Mol Med       Date:  2010-05-05       Impact factor: 6.354

2.  Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and therapy resistance.

Authors:  Vijay K Gonugunta; Gangadhara R Sareddy; Samaya Rajeshwari Krishnan; Valerie Cortez; Sudipa Saha Roy; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Mol Cancer Ther       Date:  2014-03-31       Impact factor: 6.261

Review 3.  Tuberous sclerosis complex: new insights into clinical and therapeutic approach.

Authors:  Angela Volpi; Gabriele Sala; Elena Lesma; Francesca Labriola; Marco Righetti; Rosa Maria Alfano; Mario Cozzolino
Journal:  J Nephrol       Date:  2018-11-07       Impact factor: 3.902

4.  Bifenthrin causes transcriptomic alterations in mTOR and ryanodine receptor-dependent signaling and delayed hyperactivity in developing zebrafish (Danio rerio).

Authors:  Daniel F Frank; Galen W Miller; Danielle J Harvey; Susanne M Brander; Juergen Geist; Richard E Connon; Pamela J Lein
Journal:  Aquat Toxicol       Date:  2018-04-18       Impact factor: 4.964

5.  Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesis.

Authors:  Alejandro Vazquez-Martin; Tamara Sauri-Nadal; Octavio J Menendez; Cristina Oliveras-Ferraros; Sílvia Cufí; Bruna Corominas-Faja; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

6.  Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR).

Authors:  Rosa H Jimenez; Ju-Seog Lee; Mirko Francesconi; Gastone Castellani; Nicola Neretti; Jennifer A Sanders; John Sedivy; Philip A Gruppuso
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 7.  mTOR's role in ageing: protein synthesis or autophagy?

Authors:  Sarah L Hands; Christopher G Proud; Andreas Wyttenbach
Journal:  Aging (Albany NY)       Date:  2009-07-20       Impact factor: 5.682

8.  Ras homolog enriched in brain (Rheb) enhances apoptotic signaling.

Authors:  Sascha Karassek; Carsten Berghaus; Melanie Schwarten; Christoph G Goemans; Nadine Ohse; Gerd Kock; Katharina Jockers; Sebastian Neumann; Sebastian Gottfried; Christian Herrmann; Rolf Heumann; Raphael Stoll
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

9.  TOR is a negative regulator of autophagy in Arabidopsis thaliana.

Authors:  Yimo Liu; Diane C Bassham
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

10.  Building a new bridge between metabolism, free radicals and longevity.

Authors:  Markus Ralser; Hans Lehrach
Journal:  Aging (Albany NY)       Date:  2009-09-26       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.